Literature DB >> 3158604

Role of hypertension in progressive glomerular immune injury.

L Raij, S Azar, W F Keane.   

Abstract

The relationship between hypertension, ferritin-antiferritin mesangial immune injury (FIC), and progressive glomerular damage was studied in hypertensive (8% NaCl chow) Dahl salt-sensitive rats (DS) and in spontaneously hypertensive rats (SHR). The glomeruli of SHR are protected from the increased perfusion pressure that accompanies systemic hypertension by preglomerular vasoconstriction, while the glomeruli of hypertensive DS are not. Blood pressure, serum creatinine levels, urinary protein excretion, and glomerular injury (assessed by semiquantitative morphometric analysis) were determined in 20-week-old SHR and DS with FIC. In addition, half of a group of 20-week-old SHR with FIC were uninephrectomized and progression of glomerular injury was assessed 12 weeks later. Control rats for each of the groups did not receive FIC. Our studies showed that more extensive mesangial expansion and glomerulosclerosis developed in hypertensive DS with FIC than in rats without FIC. Glomerular injury in DS with FIC affected cortical and deep glomeruli. Similarly, hypertensive SHR with FIC had minimal damage in cortical glomeruli. In deep glomeruli of SHR, mesangial expansion was similar to that of DS, but glomerulosclerosis was absent. In SHR, a 50% reduction in renal mass, a maneuver known to decrease preglomerular vasoconstriction, resulted in mesangial expansion similar to that in DS in cortical glomeruli while deep glomeruli developed mesangial expansion as well as glomerulosclerosis. Our results suggest that when hypertension and mesangial immune injury coexist with renal vasodilatation (as occurs in DS with 2 kidneys and in SHR after uninephrectomy), they act synergistically to induce progressive glomerular damage. Similar mechanisms may be operative in hypertensive humans with glomerulonephritis and may condition the rate of progression to renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158604

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  18 in total

1.  Mechanism of impaired afferent arteriole myogenic response in Dahl salt-sensitive rats: role of 20-HETE.

Authors:  YiLin Ren; Martin A D'Ambrosio; Jeffrey L Garvin; Edward L Peterson; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-02

2.  Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice.

Authors:  Malgorzata Kasztan; Brandon M Fox; Joshua S Speed; Carmen De Miguel; Eman Y Gohar; Tim M Townes; Abdullah Kutlar; Jennifer S Pollock; David M Pollock
Journal:  J Am Soc Nephrol       Date:  2017-03-27       Impact factor: 10.121

3.  Renal protective effects of calcium antagonists?

Authors:  J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

4.  Effect of salt intake on afferent arteriolar dilatation: role of connecting tubule glomerular feedback (CTGF).

Authors:  Hong Wang; Cesar A Romero; J X Masjoan Juncos; Sumit R Monu; Edward L Peterson; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2017-08-23

5.  Connecting tubule glomerular feedback in hypertension.

Authors:  Hong Wang; Martin A D'Ambrosio; Jeffrey L Garvin; Yilin Ren; Oscar A Carretero
Journal:  Hypertension       Date:  2013-08-19       Impact factor: 10.190

6.  Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation.

Authors:  D L Garcia; H G Rennke; B M Brenner; S Anderson
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

Review 7.  A Novel Mechanism of Renal Microcirculation Regulation: Connecting Tubule-Glomerular Feedback.

Authors:  Cesar A Romero; Oscar A Carretero
Journal:  Curr Hypertens Rep       Date:  2019-01-18       Impact factor: 5.369

8.  Beneficial effect of myricetin on renal functions in streptozotocin-induced diabetes.

Authors:  Filiz Ozcan; Asli Ozmen; Bahar Akkaya; Yakup Aliciguzel; Mutay Aslan
Journal:  Clin Exp Med       Date:  2011-11-15       Impact factor: 3.984

9.  Combined hydroxyurea and ETA receptor blockade reduces renal injury in the humanized sickle cell mouse.

Authors:  Crystal Taylor; Malgorzata Kasztan; Binli Tao; Jennifer S Pollock; David M Pollock
Journal:  Acta Physiol (Oxf)       Date:  2018-09-20       Impact factor: 6.311

10.  High perfusion pressure accelerates renal injury in salt-sensitive hypertension.

Authors:  Takefumi Mori; Aaron Polichnowski; Padden Glocka; Mary Kaldunski; Yusuke Ohsaki; Mingyu Liang; Allen W Cowley
Journal:  J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.